Trump Election Upset Boosts Defense, Pharma and Private Prison Shares

Defense, steel and private prison companies may fare well under Trump.

But this morning, U.S. markets were relatively stabilized, trading in positive territory around midday.

Sectors that stand to benefit under a Donald Trump administration have led the way.

Shares of pharmaceutical, private prison, steel and defense companies were flying high on Trump’s first day as president-elect, around midday.

Steel

In a research note for investors shared with ABC News, which was partly entitled "Rising Borders, Rising Walls," analysts at investment bank Jefferies said that the U.S. steel industry "should stand out as a unique beneficiary of a Trump presidency."

Analysts added that Trump’s pledge to boost infrastructure spending "may significantly boost demand for long steel products."

Around midday on Wednesday, stock in U.S. Steel Corporation was trading up around 17 percent. Another steel firm, Commercial Metals Company, was up by a similar percentage.

Private Prisons

Another sector that is trading in the green today are private prison firms.

In the wake of that decision, shares in Geo Corporation and Corrections Corporation of America took big hits.

Around midday on Wednesday, stock in private prison firm Geo Group was up more than 20 percent. Corrections Corporation of America’s shares were up a whopping 48 percent.

Defense

Defense stocks were also seeing a boost.

Throughout the campaign, Trump has promised to "rebuild our military," and he said in September that "as soon as I take office, I will ask Congress to fully eliminate the defense sequester and will submit a new budget."

Raytheon was up around 8.8 percent around midday, while Lockheed Martin was up around 6.5 percent.

Finally, pharmaceuticals are "unwinding the expectation of a Clinton win," said Rob Haworth, Senior Investment Strategist at U.S. Bank in Seattle told ABC News.

Haworth said that Clinton’s pledges to regulate drug prices had been factored into the share prices of pharmaceutical companies by investors expecting a Clinton win.

Trump’s upset victory is starting to reverse those assumptions.

The Associated Press news agency contributed to this report.